Eka Ventures
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
Flok Health raises £9.5m in a Series A led by Albion VC to deliver the first AI-operated physiotherapy clinic
Flok Health operates an AI physiotherapy clinic that autonomously diagnoses, treats and discharges patients without human intervention. The platform is available to NHS patients via a mobile app, offering on-demand appointments for musculoskeletal conditions with no waiting list.
Conveyd secures £2.5m seed round led by Eka Ventures to automate the home-buying process
Conveyd automates the UK home buying process by combining AI with legal expertise to handle conveyancing tasks faster, giving buyers clearer visibility from offer through to completion.
Cyclana Bio raises £5m pre-seed led by NfX and Eka VC to advance drug discovery for endometriosis through tissue-level therapeutics
Cyclana Bio develops tissue level disease models to discover new treatments for endometriosis, using whole tissue analysis rather than traditional cell focused drug discovery methods.
Medly AI secures £1.2m seed round led by Eka Ventures to advance AI powered education
Medly AI develops an AI-powered education platform that delivers personalised, curriculum-based learning, helping students improve exam performance through adaptive content and predicted assessments.
OXcan raises £9m Series A led by We Venture Capital and Cross-Border Impact Ventures to revolutionise early lung cancer detection
OXcan develops blood-based liquid biopsy tests using proteomics and AI to detect lung cancer at earlier stages, enabling minimally invasive screening designed to improve outcomes and reduce pressure on healthcare systems.
More venture news
- 10 Jun 2026
Capsa AICapsa AI lands £14m Series A led by TX Ventures and Pivot Investment Partners to build the AI operating system for private capital
Series AAI - 9 Jun 2026
NewOrbitNewOrbit raises £14m in a Series A led by Voyager Ventures to build the first commercial satellites for very low Earth orbit
Series ADeep Tech - 2 Jun 2026
IMU BiosciencesIMU Biosciences unlocks £40m Series A led by IQ Capital and Molten Ventures to decode the immune system with high-resolution blood analysis
Series ALife Sciences
